Profiel
Kristina Cutter is currently Chief Development Officer at Alector, Inc. since 2019.
Former positions include Head-Global Regulatory at Genentech, Inc. and Vice President-Regulatory & Safety at Halozyme Therapeutics, Inc. Education includes graduate studies at the University of Michigan School of Public Health.
Actieve functies van Kristina Cutter
| Bedrijven | Functie | Begin |
|---|---|---|
| ALECTOR, INC. | Corporate Officer/Principal | - |
Eerdere bekende functies van Kristina Cutter
| Bedrijven | Functie | Einde |
|---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
| HALOZYME THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Opleiding van Kristina Cutter
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Halozyme Therapeutics, Inc.
Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
Alector, Inc.
Alector, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for Alzheimer’s disease and other neurodegenerative disorders | Health Technology |
University of Michigan School of Public Health
University of Michigan School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















